Home » Topics » BioWorld Science

BioWorld Science
RSS

GLS1 inhibitor with antitumor activity in HCT116 xenograft model

July 14, 2022

Janssen Pharmaceutica identifies new Mcl-1 inhibitors

July 14, 2022

Pfizer synthesizes IL-2 production inhibitors

July 14, 2022

Merck & Co. discloses new DNA polymerase inhibitors

July 14, 2022

UCB SA patents DRD1 PAMs

July 14, 2022

Novel genetic polymorphism associated with macroangiopathy risk

July 14, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Novel genetic loci found for venous thromboembolism

July 13, 2022

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

July 13, 2022

Targeting IL-33 release may be an approach for treating HCC

July 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...